Cargando…

A Digital Health Application Allowing a Personalized Low-Glycemic Nutrition for the Prophylaxis of Migraine: Proof-of-Concept Data from a Retrospective Cohort Study

Background: Migraine is a headache disorder with the highest socioeconomic burden. The aim of this study was to deliver the first proof-of-concept data of the potential role of an individual low-glycemic diet provided by a novel digital health application in the prophylaxis of migraine. Methods: We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schröder, Torsten, Kühn, Gianna, Kordowski, Anna, Jahromi, Soodeh Razeghi, Gendolla, Astrid, Evers, Stefan, Gaul, Charly, Thaçi, Diamant, König, Inke Regina, Sina, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878080/ https://www.ncbi.nlm.nih.gov/pubmed/35207390 http://dx.doi.org/10.3390/jcm11041117

Ejemplares similares

A Digital Therapeutic Allowing a Personalized Low-Glycemic Nutrition for the Prophylaxis of Migraine: Real World Data from Two Prospective Studies
por: Lelleck, Vivian Valeska, et al.
Publicado: (2022)

Efficacy of the Digital Therapeutic sinCephalea in the prophylaxis of migraine in patients with episodic migraine: study protocol for a digital, randomized, open-label, standard treatment controlled trial
por: Schröder, Torsten, et al.
Publicado: (2022)

Cinnarizine for the prophylaxis of migraine associated vertigo: a retrospective study
por: Taghdiri, Foad, et al.
Publicado: (2014)

Real-life use of onabotulinumtoxinA reduces healthcare resource utilization in individuals with chronic migraine: the REPOSE study
por: Kollewe, Katja, et al.
Publicado: (2021)

Triptan efficacy does not predict onabotulinumtoxinA efficacy but improves with onabotulinumtoxinA response in chronic migraine patients
por: Eren, Ozan E., et al.
Publicado: (2020)

The effect of body fat mass and fat free mass on migraine headache
por: Jahromi, Soodeh Razeghi, et al.
Publicado: (2013)

An investigation of oxidant/antioxidant balance in patients with migraine: a case-control study
por: Togha, Mansoureh, et al.
Publicado: (2019)

Cardiovascular risk factors and migraine without aura: A case-control study
por: Harandi, Samaneh Aalami, et al.
Publicado: (2013)

Cinnarizine in refractory migraine prophylaxis: efficacy and tolerability. A comparison with sodium valproate
por: Togha, Mansoureh, et al.
Publicado: (2008)

Cinnarizine in refractory migraine prophylaxis: efficacy and tolerability. A comparison with sodium valproate
por: Mansoureh, Togha, et al.
Publicado: (2008)

Gut-brain Axis and migraine headache: a comprehensive review
por: Arzani, Mahsa, et al.
Publicado: (2020)

Dietary pattern and risk of multiple sclerosis
por: Jahromi, Soodeh Razeghi, et al.
Publicado: (2012)

The association between dairy intake and migraine odds among pediatrics and adolescents: A case-control study
por: ARIYANFAR, Shadi, et al.
Publicado: (2022)

B vitamins and their combination could reduce migraine headaches: A randomized double-blind controlled trial
por: Nematgorgani, Shiva, et al.
Publicado: (2022)

The association of dietary and lifestyle indices for hyperinsulinemia with odds of non-alcoholic fatty liver disease in Iranian adults: a case–control study
por: Momeni, Aref, et al.
Publicado: (2023)

Efficacy of Cognitive-Behavioral Therapy for the Prophylaxis of Migraine in Adults: A Three-Armed Randomized Controlled Trial
por: Klan, Timo, et al.
Publicado: (2022)

The Association Between Dietary Acid Load and Odds of Migraine: A Case–Control Survey
por: Mousavi, Maryam, et al.
Publicado: (2021)

EHMTI-0031. Efficacy and safety of venlafaxine for the treatment of chronic migraine: a randomized, double-blind, controlled trial
por: Togha, M, et al.
Publicado: (2014)

EHMTI-0292. The effect of body fat mass and fat free mass on migraine headache
por: jahromi, S Razeghi, et al.
Publicado: (2014)

Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial
por: Gaul, Charly, et al.
Publicado: (2015)

Real-world evidence data on the monoclonal antibody erenumab in migraine prevention: perspectives of treating physicians in Germany
por: Straube, Andreas, et al.
Publicado: (2021)

Palatinose(TM) (Isomaltulose) and Prebiotic Inulin-Type Fructans Have Beneficial Effects on Glycemic Response and Gut Microbiota Composition in Healthy Volunteers—A Real-Life, Retrospective Study of a Cohort That Participated in a Digital Nutrition Program
por: Kordowski, Anna, et al.
Publicado: (2022)

Association of diet and headache
por: Razeghi Jahromi, Soodeh, et al.
Publicado: (2019)

SAT655 Modifying Effects Of Dash Diet On Food Addiction Two Years After Sleeve Gastrostomy: A Randomized Controlled Clinical Trial
por: Ariyanfar, Shadi, et al.
Publicado: (2023)

The Mitochondrial Biomarkers FGF-21 and GDF-15 in Patients with Episodic and Chronic Migraine
por: Burow, Philipp, et al.
Publicado: (2021)

Is prednisone still a reasonable option in the treatment of withdrawal headache in patients with chronic migraine and medication overuse headache in the age of CGRP antibodies? A narrative review
por: Kaltseis, Katharina, et al.
Publicado: (2022)

An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study
por: Ahmed, Fayyaz, et al.
Publicado: (2019)

Real-life use of onabotulinumtoxinA for symptom relief in patients with chronic migraine: REPOSE study methodology and baseline data
por: Davies, Brendan, et al.
Publicado: (2017)

Prevention of medication overuse and medication overuse headache in patients with migraine: a randomized, controlled, parallel, allocation-blinded, multicenter, prospective trial using a mobile software application
por: Diener, Hans-Christoph, et al.
Publicado: (2022)

Aerobic endurance training versus relaxation training in patients with migraine (ARMIG): study protocol for a randomized controlled trial
por: Totzeck, Andreas, et al.
Publicado: (2012)

Study protocol to investigate the efficacy of confocal laser endomicroscopy-based selective single-elimination diet over standard fivefold elimination diet in patients with endomicroscopically proven food intolerance: app-assisted, monocentric, double-blind, randomised and controlled trial in Germany
por: Heßler, Nicole, et al.
Publicado: (2023)

Recombinant λ-phage nanobioparticles for tumor therapy in mice models
por: Ghaemi, Amir, et al.
Publicado: (2010)

Effect of oral genistein administration in early and late phases of allergic encephalomyelitis
por: Jahromi, Soodeh Razeghi, et al.
Publicado: (2014)

The effects of vitamin D supplementation on interictal serum levels of calcitonin gene-related peptide (CGRP) in episodic migraine patients: post hoc analysis of a randomized double-blind placebo-controlled trial
por: Ghorbani, Zeinab, et al.
Publicado: (2020)

Prevention of migraine with monoclonal antibodies against CGRP or the CGRP receptor: Addition to the S1 guideline: Therapy of migraine attacks and prevention of migraine. Recommendations of the Germany Society of Neurology and the German Migraine and Headache Society
por: Diener, Hans-Christoph, et al.
Publicado: (2020)

Headache in Behcet’s disease: types and characteristics
por: Moghaddassi, Maryam, et al.
Publicado: (2016)

The effect of body mass index on the morbidity and outcomes of COVID-19 in Iranian patients with multiple sclerosis
por: Rezaeimanesh, Nasim, et al.
Publicado: (2023)

Cluster-Kopfschmerz nach COVID-19-Impfung?
por: Gaul, Charly
Publicado: (2022)

Cluster-Kopfschmerz nach COVID-19-Impfung?
por: Gaul, Charly
Publicado: (2022)

Impact of a 12-week open-label placebo treatment on headache days in episodic and chronic migraine: a study protocol for a parallel-group, multicentre, randomised controlled trial
por: Schmidt, Katharina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qrjv2r398scuoq8f0l361tidri